$CCCP
Crona Corp.

2024 Q4 Form 10-Q Financial Statement

#000147793224006213 Filed on October 04, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $14.04K
YoY Change -39.06%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.370K
YoY Change -7.3%
% of Gross Profit
Operating Expenses $21.41K
YoY Change -39.21%
Operating Profit -$27.11K
YoY Change -30.86%
Interest Expense $5.693K
YoY Change 43.08%
% of Operating Profit
Other Income/Expense, Net -$5.693K
YoY Change 43.08%
Pretax Income -$27.11K
YoY Change -30.84%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$27.11K
YoY Change -30.86%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 6.088M shares 6.588M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment $16.31K
YoY Change -24.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $53.82K
YoY Change -36.01%
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $53.82K
Total Assets $53.82K
YoY Change -37.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.231K
YoY Change 1319.14%
Accrued Expenses $2.000K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $190.9K
YoY Change 41.76%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $100.0K
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $190.9K
Total Long-Term Liabilities $100.0K
Total Liabilities $290.9K
YoY Change 23.96%
SHAREHOLDERS EQUITY
Retained Earnings -$275.4K
YoY Change 47.86%
Common Stock $6.588K
YoY Change 8.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$237.1K
YoY Change
Total Liabilities & Shareholders Equity $53.82K
YoY Change -37.57%

Cashflow Statement

Concept 2024 Q4 2024 Q2
OPERATING ACTIVITIES
Net Income -$27.11K
YoY Change -30.86%
Depreciation, Depletion And Amortization $7.370K
YoY Change -7.3%
Cash From Operating Activities -$11.00K
YoY Change -54.51%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.00K
YoY Change -880.14%
NET CHANGE
Cash From Operating Activities -11.00K
Cash From Investing Activities
Cash From Financing Activities 11.00K
Net Change In Cash 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$11.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6587500 shares
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
crona Amortization On Convertible Promissory Note
AmortizationOnConvertiblePromissoryNote
1863 usd
crona Amortization On Convertible Promissory Note
AmortizationOnConvertiblePromissoryNote
6567 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
14743 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15898 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3942 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10734 usd
us-gaap Professional Fees
ProfessionalFees
13000 usd
us-gaap Professional Fees
ProfessionalFees
108352 usd
us-gaap Operating Expenses
OperatingExpenses
33548 usd
us-gaap Operating Expenses
OperatingExpenses
141551 usd
us-gaap Interest Expense
InterestExpense
11397 usd
us-gaap Interest Expense
InterestExpense
7891 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.001
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11397 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7891 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-44945 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-149442 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-44945 usd
us-gaap Net Income Loss
NetIncomeLoss
-149442 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-197 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44945 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-149639 usd
crona Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
crona Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.02
crona Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6176541 shares
crona Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6087500 shares
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
132500 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
130637 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001696411
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6587500 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
100000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-216180
dei Entity Registrant Name
EntityRegistrantName
CRONA CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2574778
dei Entity Address Address Line1
EntityAddressAddressLine1
422 Richards Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 170
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6B 2Z4
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
998-9449
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
CCCP
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6087500 shares
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2024Q2 crona Amortization On Convertible Promissory Note
AmortizationOnConvertiblePromissoryNote
0 usd
CY2023Q2 crona Amortization On Convertible Promissory Note
AmortizationOnConvertiblePromissoryNote
4238 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7371 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7950 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2043 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7503 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
12000 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
15534 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
21414 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
35225 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
5693 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
3979 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5693 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3979 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27107 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-39204 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-27107 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39204 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-160 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27107 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39364 usd
CY2024Q2 crona Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2023Q2 crona Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2024Q2 crona Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6176541 shares
CY2023Q2 crona Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6087500 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
690 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-37 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-110239 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-109586 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-109586 usd
CY2023Q2 crona Shares Issued For Services Amount
SharesIssuedForServicesAmount
500 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-160 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39204 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-148450 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-192124 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17838 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-209962 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-209962 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-27107 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-237069 usd
crona Repayments Of Related Party Debts
RepaymentsOfRelatedPartyDebts
0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
100000 usd
CY2024Q2 us-gaap Other Notes Payable
OtherNotesPayable
100000 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6587500 shares

Files In Submission

Name View Source Status
crona-20240630_pre.xml Edgar Link unprocessable
crona-20240630_cal.xml Edgar Link unprocessable
0001477932-24-006213-index-headers.html Edgar Link pending
0001477932-24-006213-index.html Edgar Link pending
0001477932-24-006213.txt Edgar Link pending
0001477932-24-006213-xbrl.zip Edgar Link pending
crona-20240630.xsd Edgar Link pending
crona_10q.htm Edgar Link pending
crona_ex311.htm Edgar Link pending
crona_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
crona_10q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
crona-20240630_lab.xml Edgar Link unprocessable
crona-20240630_def.xml Edgar Link unprocessable